C

Clearside Biomedical
D

CLSD

1.10500
USD
0.03
(2.79%)
Market Closed
Volume
3,911
EPS
-0
Div Yield
-
P/E
-2
Market Cap
83,807,072
OverviewSignalsIdeasNews
Related Instruments
    A
    ACRS
    -0.14500
    (-6.62%)
    2.04500 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    ALIM
    0
    (0%)
    0.000000 USD
    A
    AUPH
    -0.20500
    (-2.46%)
    8.12000 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    K
    KALA
    0.01000
    (0.15%)
    6.87000 USD
    O
    OCUL
    -0.77000
    (-7.75%)
    9.16000 USD
    S
    SNGX
    -0.15500
    (-4.21%)
    3.52500 USD
    V
    VTGN
    -0.10000
    (-3.68%)
    2.62000 USD
    More
News

Title: Clearside Biomedical

Sector: Healthcare
Industry: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.